Search results
809 results
for term "advanced"
-
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C...-related hepatitis (92 men and 58 women, age 50.6 (SD 12.5) years on the same day. Necro-inflammatory activity and the degree of steatosis at biopsy were also evaluated. Results: The areas under the curve for the prediction of significant fibrosis (>F2),advancedfibrosis (>F3) or cirrhosis were 0.91, 0.99 and 0 ...
-
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease...April 2008 ABSTRACT Background: Clinical predictors ofadvancednon-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors foradvanceddisease, this study analysed 827 patients with NAFLD at two ...
-
IDDF2019-ABS-0078 A pre-operative prognosis score for advanced hepatocellular carcinoma (hcc) patients underwent resection...IDDF2019-ABS-0078 A PRE-OPERATIVE PROGNOSIS SCORE FORADVANCEDHEPATOCELLULAR CARCINOMA (HCC) PATIENTS UNDERWENT RESECTION Han Xiao*, Mengchao Wei, Shuling Chen, Zhenwei Peng, Sui Peng, Ming Kuang. The First Affiliated Hospital of Sun Yat-sen University, China 10.1136/-2019-IDDFabstracts.256 ...
-
Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease...AbstractObjective Liver stiffness measurement (LSM) is a tool used to screen for significant fibrosis and portal hypertension. The aim of this retrospective multicentre study was to develop an easy tool using LSM for clinical outcomes inadvancedchronic liver disease (ACLD) patients ...
-
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease...was to compare the diagnostic performance of simple non-invasive tests in identifyingadvancedfibrosis among patients with biopsy-proven NAFLD. Methods Consecutive patients with biopsy proven NAFLD were recruited from the Newcastle Hospitals Fatty Liver Clinic from 2003 to 2009. The AST/ALT ratio, AST ...
-
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C...ORIGINAL ARTICLE Safety and on-treatment efficacy of telaprevir: the early access programme for patients withadvancedhepatitis C M Colombo,1 I Fernández,2 D Abdurakhmanov,3 P A Ferreira,4 S I Strasser,5 P Urbanek,6 C Moreno,7 A Streinu-Cercel,8 A Verheyen,9 W Iraqi,10 R DeMasi,11 A Hill,12 J M ...
-
IDDF2019-ABS-0082 Microvascular invasion at primary resection guiding the therapeutic options of recurrent intermediate-advanced hepatocellular carcinoma...IDDF2019-ABS-0078 A PRE-OPERATIVE PROGNOSIS SCORE FORADVANCEDHEPATOCELLULAR CARCINOMA (HCC) PATIENTS UNDERWENT RESECTION Han Xiao*, Mengchao Wei, Shuling Chen, Zhenwei Peng, Sui Peng, Ming Kuang. The First Affiliated Hospital of Sun Yat-sen University, China 10.1136/-2019-IDDFabstracts.256 ...
-
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes...; thomas.reiberger@meduniwien.ac.at Received 3 August 2020 Revised 18 October 2020 Accepted 19 October 2020 AbstractObjective Systemic inflammation promotes the development of clinical events in patients withadvancedchronic liver disease (ACLD). We assessed whether (1) non-selective beta blocker (NSBB ...
-
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis...kg/m2; 33% had type 2 diabetes; 30% hadadvancedfibrosis). AUROCs of individual LSM-VCTE, FIB-4 and NFS foradvancedfibrosis were 0.85, 0.76 and 0.73. Sequential combination of FIB-4 cut-offs (<1.3; 2.67) followed by LSM-VCTE cut-offs (<8.0; 10.0 kPa) to rule-in or rule-outadvancedfibrosis had ...
-
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography...was to examine the prevalence of NAFLD andadvancedfibrosis in the general Hong Kong Chinese population. Methods Subjects were recruited from the community by random selection from the government census database. Liver fat and fibrosis were assessed by protonmagnetic resonance spectroscopy and transient ...
